Indonesia builds largest plasma derivative fractionation plant in Southeast Asia

social dynamics1mos agoupdate PrintEnterprise

0 0

Indonesia has a long history of100% Dependence on imported plasma derivativesThe status quo is about to take a turn for the worse. ByIndonesia Investment Authority (INA)Indonesia is working togetherKorea SK GroupSK PlasmaConstruction in the countryFirst and largest plasma derivative (PDMP) fractionation plant in Southeast Asia, which is expected to end the history of total dependence on imports.

INA is responsible forESGThe vice president of Indonesia's plasma affairs said that Indonesia had previously relied on imports to meet all of its plasma needs, and that the plant being built as a result of the partnership was located inKarawang International Industrial ParkProgramsCommissioned in the fourth quarter of 2026(math.) genusAnnual processing capacity of 600,000 liters of plasmawill produceAlbumin, immunoglobulinand other plasma-derived drugs (PODP). The program is a joint venture between INA and SK PlasmaPT SKPlasma Core IndonesiaAdvancement (Investment agreement signed on November 14, 2024), with INA as the second largest shareholder, which is alsoKorean companies succeed in attracting INA investment for the first timeThe

SK Plasma has been licensed by the Ministry of Health to conduct PDMP business and establish a joint venture. When the plant is completed, it will not only guaranteeSupply of emergency and surgical drugs such as albuminThe new technology will also push Indonesia to move from a "market" to a "market"."Producer countries"RealizationSelf-sufficiency in plasma derivatives. During the construction period, SK Plasma will be operated through theContract Manufacturing Organization (CMO) ModelSecurity of supply: Indonesia to KoreaAndong FactoryProvide plasma from local donors and return the resulting PDMP to Indonesia; also provide initial training for local Indonesian workers to accelerate production stabilization.

Plasma, as a yellowish liquid in blood 92% for water, assumes key functions such as transporting cellular wastes to the liver and kidneys for excretion, maintaining body temperature, etc., and its fractionated products are vital to medical treatment. This cooperation relies on bothSK Plasma's strengths in PDMP plant operations and technologyIt is also a reflection of Indonesia'sDetermination to promote national ownership in the medical fieldThe

# Social Dynamics